Prostate (Neoplasia Hyperplasia benign)

LE WE PMID CA

Prostate (Neoplasia Hyperplasia benign)

2298

Prostata (Neubildung benigne Hyperplasie)

Prostate (Neoplasia Hyperplasia benign)

Silodosin

2008 1	Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials. [18595932] BMJ 337(-): a449 (2008)
2006 2	Benign prostatic hyperplasia: treatment in primary care. [16960209] BMJ 333(7567): 535-9 (2006)
2001 3	Benign prostatic hyperplasia. [11691764] BMJ 323(7320): 1042-6 (2001)
2006 4	Doxazosin in the treatment of benign prostatic hypertrophy: an update. [18046916] Clin Interv Aging 1(4): 389-401 (2006)
1997 5	Treatment options for benign prostatic hyperplasia. [9266125] Can Fam Physician 43(-): 1395-404 (1997)
2006 6	Management of benign prostate hyperplasia: an overview of alpha-adrenergic antagonist. [16880603] Biol Pharm Bull 29(8): 1554-8 (2006)
2009 7	Finasteride in the treatment of patients with benign prostatic hyperplasia: a review. [19707263] Ther Clin Risk Manag 5(3): 535-45 (2009)
2007 8	Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH). [18360626] Ther Clin Risk Manag 3(1): 181-96 (2007)
2004 9	Preventing progression in men with mild symptoms of benign prostatic hyperplasia: a potential role for phytotherapy. [16985600] Rev Urol 6(4): 187-92 (2004)
1998 10	Benign changes in the prostate with ageing. [9883261] Br J Urol 82 Suppl 1(-): 44-6 (1998)
1998 11	A critical evaluation of technological innovations in the treatment of symptomatic benign prostatic hyperplasia. [9589019] Br J Urol 81 Suppl 1(-): 56-63 (1998)
1998 12	Treatment of benign prostatic hyperplasia and hypertension in elderly hypertensive patients. [9589018] Br J Urol 81 Suppl 1(-): 51-5 (1998)
1998 13	Current status of research on prostate-selective alpha 1-antagonists. [9589017] Br J Urol 81 Suppl 1(-): 48-50 (1998)
1998 14	Pharmacotherapy for benign prostatic hyperplasia--the potential for alpha 1-adrenoceptor subtype-specific blockade. [9589016] Br J Urol 81 Suppl 1(-): 34-47; discussion 64-6 (1998)
1998 15	Clinical pharmacology of modern antihypertensive agents and their interaction with alpha-adrenoceptor antagonists. [9589011] Br J Urol 81 Suppl 1(-): 6-16; discussion 64-6 (1998)
1997 16	Alpha adrenoceptor blockade in the treatment of benign prostatic hyperplasia: past, present and future. [9352686] Br J Urol 80(4): 521-32 (1997)
2008 17	5-Alpha reductase inhibitors in men with an enlarged prostate: an evaluation of outcomes and therapeutic alternatives. [18611088] Am J Manag Care 14(5 Suppl 2): S148-53 (2008)
2005 18	Evaluation and medical management of benign prostatic hyperplasia. [16212149] Mayo Clin Proc 80(10): 1356-62 (2005)
2011 19	[Clinical management of patient with benign prostatic hyperplasia in Spain]. [21959065] Actas Urol Esp 35(10): 580-8 (2011)
2008 20	Benign prostatic hyperplasia. Part 2--management. [18219042] BMJ 336(7637): 206-10 (2008)
2008 21	Benign prostatic hyperplasia. Part 1--diagnosis. [18202067] BMJ 336(7636): 146-9 (2008)
2007 22	Medical treatment of benign prostatic hyperplasia. [17308208] Postgrad Med J 83(976): 73-8 (2007)
2011 23	Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia. [21753871] Clin Interv Aging 6(-): 161-72 (2011)
2007 24	Update on the use of dutasteride in the management of benign prostatic hypertrophy. [18044081] Clin Interv Aging 2(1): 99-104 (2007)
2008 25	Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily. [18982921] Clin Interv Aging 3(3): 511-24 (2008)
2010 26	Silodosin in the treatment of benign prostatic hyperplasia. [21116335] Drug Des Devel Ther 4(-): 291-7 (2010)
2010 27	Prostatic atrophy. Clinicopathological significance. [20815946] Int Braz J Urol 36(4): 401-9 (2010)
2008 28	Current status of 5alpha-reductase inhibitors in the treatment of benign hyperplasia of prostate. [18445985] Indian J Med Sci 62(4): 167-75 (2008)
2011 29	Endourologic procedures for benign prostatic hyperplasia: review of indications and outcomes. [21910092] Urol J 8(3): 171-6 (2011)
2011 30	Serenoa repens extract in the treatment of benign prostatic hyperplasia. [21969849] Ther Adv Urol 3(4): 193-8 (2011)
2011 31	Holmium laser enucleation of prostate for benign prostatic hyperplasia: seoul national university hospital experience. [21468284] Int Neurourol J 15(1): 29-34 (2011)
2010 32	Current status of 5alpha-reductase inhibitors in the management of lower urinary tract symptoms and BPH. [19956956] World J Urol 28(1): 9-15 (2010)
2010 33	Relevance of benign prostatic hyperplasia and associated conditions for urologists, health care systems, and society. [20076962] World J Urol 28(1): 1-2 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Prostate (Neoplasia Hyperplasia benign).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Prostate (Neoplasia Hyperplasia benign).php on line 92